Cibc Private Wealth Group, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,100 shares of MDGL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,100
Previous 30,051
89.68%
Holding current value
$1.05 Million
Previous $8.42 Million
92.2%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
295Shares Held
22MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$843 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$695 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$690 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$678 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$672 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.82B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...